![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Dermatofibrosarcoma Protuberans - 19 Studies Found
Completed |
: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans : Dermatofibrosarcoma Protuberans : 2005-10-20 : Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days |
Completed |
: Imatinib in Dermatofibrosarcoma Protuberans (DFSP) : Dermatofibrosarcoma : 2005-07-20 : Drug: Imatinib (Glivec) |
Terminated |
: Phase II Pazopanib Study in Advanced Dermatofibrosarcomas : Dermatofibrosarcomas of DARIER FERRAND(DFSP) : 2010-01-28 : Drug: Pazopanib Administration of pazopanib per os 800mg/ qd during 6 months until stable response accor |
Completed |
: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans :
: |
Completed |
: Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans : Soft Tissue Neoplasms : 2005-09-12 |
Completed |
: Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma : Sarcoma : 2004-06-10 :
|
Completed |
: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes :
|
Completed |
: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma :
|
Completed |
: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma :
|
Completed |
: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma :
|